 Susana Arrigain
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 31 | 2023 | 566 | 2.640 |
Why?
| | Lung Transplantation | 9 | 2024 | 289 | 1.020 |
Why?
| | Kidney Transplantation | 9 | 2024 | 672 | 0.920 |
Why?
| | Glomerular Filtration Rate | 22 | 2023 | 711 | 0.890 |
Why?
| | Tissue Donors | 6 | 2024 | 391 | 0.860 |
Why?
| | Registries | 26 | 2024 | 1896 | 0.790 |
Why?
| | Kidney Failure, Chronic | 10 | 2021 | 547 | 0.570 |
Why?
| | Waiting Lists | 5 | 2024 | 237 | 0.550 |
Why?
| | Tissue and Organ Procurement | 5 | 2024 | 288 | 0.450 |
Why?
| | Proportional Hazards Models | 18 | 2023 | 1201 | 0.450 |
Why?
| | Body Mass Index | 8 | 2024 | 2273 | 0.450 |
Why?
| | End Stage Liver Disease | 2 | 2024 | 78 | 0.410 |
Why?
| | Middle Aged | 57 | 2024 | 31154 | 0.410 |
Why?
| | Cause of Death | 8 | 2018 | 393 | 0.400 |
Why?
| | Liver Transplantation | 3 | 2024 | 831 | 0.400 |
Why?
| | Graft Survival | 4 | 2024 | 512 | 0.400 |
Why?
| | Aged | 49 | 2024 | 22103 | 0.400 |
Why?
| | Male | 76 | 2024 | 63681 | 0.370 |
Why?
| | Organ Transplantation | 2 | 2024 | 228 | 0.370 |
Why?
| | Living Donors | 6 | 2023 | 287 | 0.360 |
Why?
| | Social Determinants of Health | 2 | 2024 | 221 | 0.360 |
Why?
| | Female | 76 | 2024 | 68776 | 0.350 |
Why?
| | Acute Kidney Injury | 6 | 2023 | 790 | 0.350 |
Why?
| | Risk Factors | 27 | 2024 | 9765 | 0.320 |
Why?
| | Health Expenditures | 2 | 2022 | 179 | 0.320 |
Why?
| | United States | 24 | 2024 | 13903 | 0.310 |
Why?
| | Graft Rejection | 5 | 2024 | 598 | 0.310 |
Why?
| | Aged, 80 and over | 23 | 2019 | 7086 | 0.300 |
Why?
| | Humans | 88 | 2024 | 129650 | 0.300 |
Why?
| | Cytomegalovirus Infections | 3 | 2024 | 189 | 0.280 |
Why?
| | Ohio | 10 | 2017 | 152 | 0.280 |
Why?
| | Renal Dialysis | 7 | 2018 | 423 | 0.270 |
Why?
| | Kidney Diseases | 4 | 2011 | 384 | 0.270 |
Why?
| | Electronic Health Records | 7 | 2017 | 975 | 0.270 |
Why?
| | Kaplan-Meier Estimate | 10 | 2021 | 857 | 0.270 |
Why?
| | Retrospective Studies | 29 | 2024 | 14518 | 0.270 |
Why?
| | Transplant Recipients | 4 | 2024 | 162 | 0.260 |
Why?
| | Follow-Up Studies | 14 | 2024 | 4897 | 0.250 |
Why?
| | Adult | 34 | 2024 | 35576 | 0.250 |
Why?
| | Health Services Accessibility | 4 | 2024 | 902 | 0.230 |
Why?
| | Patient Navigation | 2 | 2017 | 79 | 0.230 |
Why?
| | Kidney | 7 | 2021 | 1385 | 0.230 |
Why?
| | Body Height | 1 | 2005 | 193 | 0.220 |
Why?
| | Obesity | 6 | 2024 | 2883 | 0.210 |
Why?
| | Knee Injuries | 1 | 2005 | 99 | 0.210 |
Why?
| | Treatment Outcome | 17 | 2024 | 10230 | 0.210 |
Why?
| | Severity of Illness Index | 9 | 2024 | 2742 | 0.210 |
Why?
| | Nephrologists | 1 | 2023 | 12 | 0.210 |
Why?
| | Nephrology | 2 | 2021 | 60 | 0.210 |
Why?
| | Travel | 2 | 2020 | 122 | 0.200 |
Why?
| | Healthcare Disparities | 3 | 2024 | 578 | 0.200 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2005 | 140 | 0.200 |
Why?
| | Informed Consent | 1 | 2024 | 170 | 0.200 |
Why?
| | Donor Selection | 2 | 2021 | 75 | 0.200 |
Why?
| | Time Factors | 14 | 2021 | 6556 | 0.200 |
Why?
| | Risk Assessment | 11 | 2021 | 3240 | 0.190 |
Why?
| | Nutrition Surveys | 4 | 2021 | 260 | 0.190 |
Why?
| | Stomach Diseases | 1 | 2021 | 20 | 0.180 |
Why?
| | Medicare | 2 | 2024 | 720 | 0.180 |
Why?
| | Histamine H2 Antagonists | 1 | 2021 | 29 | 0.180 |
Why?
| | Disease Progression | 9 | 2021 | 2635 | 0.180 |
Why?
| | Insulin Resistance | 3 | 2020 | 1165 | 0.180 |
Why?
| | Transplants | 1 | 2021 | 35 | 0.180 |
Why?
| | Comorbidity | 8 | 2021 | 1547 | 0.170 |
Why?
| | Proteinuria | 1 | 2021 | 91 | 0.170 |
Why?
| | Body Weight | 1 | 2005 | 940 | 0.170 |
Why?
| | Proton Pump Inhibitors | 1 | 2021 | 100 | 0.170 |
Why?
| | Abdominal Fat | 1 | 2020 | 40 | 0.170 |
Why?
| | Age Factors | 9 | 2021 | 3144 | 0.170 |
Why?
| | Sex Factors | 6 | 2024 | 1968 | 0.170 |
Why?
| | Ventricular Function, Left | 3 | 2019 | 527 | 0.170 |
Why?
| | Nephrectomy | 1 | 2021 | 160 | 0.160 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 282 | 0.160 |
Why?
| | Chi-Square Distribution | 7 | 2016 | 516 | 0.160 |
Why?
| | Magnesium | 1 | 2020 | 153 | 0.160 |
Why?
| | Heart Transplantation | 2 | 2021 | 721 | 0.160 |
Why?
| | Hypertension | 5 | 2017 | 1242 | 0.160 |
Why?
| | Prognosis | 8 | 2024 | 3794 | 0.160 |
Why?
| | Cohort Studies | 11 | 2020 | 5420 | 0.160 |
Why?
| | Career Choice | 1 | 2021 | 207 | 0.160 |
Why?
| | Mortality | 2 | 2018 | 307 | 0.150 |
Why?
| | Internal Medicine | 1 | 2021 | 247 | 0.150 |
Why?
| | Propensity Score | 5 | 2020 | 265 | 0.150 |
Why?
| | Resource Allocation | 1 | 2018 | 39 | 0.150 |
Why?
| | Immunologic Factors | 1 | 2020 | 231 | 0.150 |
Why?
| | Stroke Volume | 2 | 2019 | 592 | 0.150 |
Why?
| | Terminology as Topic | 1 | 2019 | 204 | 0.150 |
Why?
| | Program Evaluation | 2 | 2021 | 875 | 0.140 |
Why?
| | Gout Suppressants | 1 | 2017 | 17 | 0.140 |
Why?
| | Medicaid | 1 | 2022 | 433 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2017 | 44 | 0.140 |
Why?
| | Hypernatremia | 1 | 2017 | 9 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 112 | 0.140 |
Why?
| | Health Records, Personal | 1 | 2017 | 26 | 0.140 |
Why?
| | Cholesterol, HDL | 1 | 2018 | 205 | 0.140 |
Why?
| | Health Care Costs | 1 | 2020 | 367 | 0.140 |
Why?
| | Hyponatremia | 1 | 2017 | 40 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 121 | 0.140 |
Why?
| | Logistic Models | 7 | 2015 | 1988 | 0.130 |
Why?
| | Uric Acid | 1 | 2017 | 161 | 0.130 |
Why?
| | Incidence | 6 | 2021 | 2644 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 3 | 2007 | 499 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 218 | 0.130 |
Why?
| | Creatinine | 3 | 2023 | 491 | 0.130 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2020 | 320 | 0.130 |
Why?
| | Cytomegalovirus | 3 | 2024 | 154 | 0.120 |
Why?
| | Contrast Media | 1 | 2018 | 394 | 0.120 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 284 | 0.120 |
Why?
| | Vascular Resistance | 2 | 2015 | 371 | 0.120 |
Why?
| | Hypokalemia | 1 | 2015 | 24 | 0.120 |
Why?
| | Diet, Reducing | 1 | 2015 | 87 | 0.120 |
Why?
| | Hyperkalemia | 1 | 2015 | 24 | 0.120 |
Why?
| | Catheters | 1 | 2015 | 68 | 0.120 |
Why?
| | Multivariate Analysis | 7 | 2016 | 1502 | 0.120 |
Why?
| | Electric Countershock | 1 | 2015 | 105 | 0.120 |
Why?
| | Program Development | 2 | 2015 | 357 | 0.110 |
Why?
| | Patient Selection | 1 | 2018 | 663 | 0.110 |
Why?
| | Adipokines | 1 | 2014 | 47 | 0.110 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 248 | 0.110 |
Why?
| | Blood Pressure | 3 | 2017 | 1736 | 0.110 |
Why?
| | Chelating Agents | 1 | 2014 | 68 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 759 | 0.110 |
Why?
| | Atrial Fibrillation | 1 | 2018 | 376 | 0.110 |
Why?
| | Death, Sudden, Cardiac | 1 | 2015 | 179 | 0.110 |
Why?
| | Patient Education as Topic | 2 | 2017 | 743 | 0.110 |
Why?
| | Primary Prevention | 1 | 2015 | 188 | 0.110 |
Why?
| | Odds Ratio | 4 | 2014 | 1023 | 0.110 |
Why?
| | Phosphates | 1 | 2014 | 180 | 0.100 |
Why?
| | Lung Diseases | 1 | 2019 | 742 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2016 | 985 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 1 | 2015 | 317 | 0.100 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 146 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 2 | 2010 | 68 | 0.100 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2012 | 43 | 0.100 |
Why?
| | Defibrillators, Implantable | 1 | 2015 | 300 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 385 | 0.090 |
Why?
| | Follicular Fluid | 1 | 2011 | 5 | 0.090 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2011 | 7 | 0.090 |
Why?
| | Carotid Stenosis | 1 | 2012 | 84 | 0.090 |
Why?
| | Bicarbonates | 1 | 2011 | 42 | 0.090 |
Why?
| | Bariatric Surgery | 1 | 2014 | 193 | 0.090 |
Why?
| | Exercise Therapy | 1 | 2015 | 412 | 0.090 |
Why?
| | Internship and Residency | 1 | 2021 | 1053 | 0.090 |
Why?
| | Sunscreening Agents | 1 | 2011 | 23 | 0.090 |
Why?
| | Coronary Disease | 2 | 2016 | 385 | 0.090 |
Why?
| | Infertility | 1 | 2011 | 51 | 0.090 |
Why?
| | Survival Rate | 4 | 2019 | 1877 | 0.090 |
Why?
| | Blood Flow Velocity | 1 | 2012 | 404 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2010 | 2441 | 0.090 |
Why?
| | Hypoglycemic Agents | 2 | 2010 | 1220 | 0.090 |
Why?
| | Stents | 2 | 2012 | 504 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 372 | 0.090 |
Why?
| | Motivation | 1 | 2015 | 546 | 0.090 |
Why?
| | Adipose Tissue | 1 | 2014 | 592 | 0.080 |
Why?
| | Hepatitis, Autoimmune | 1 | 2010 | 20 | 0.080 |
Why?
| | Chronic Disease | 6 | 2011 | 1720 | 0.080 |
Why?
| | Triglycerides | 1 | 2012 | 527 | 0.080 |
Why?
| | Motor Activity | 1 | 2014 | 676 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2736 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 339 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2011 | 176 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2014 | 608 | 0.080 |
Why?
| | Health Surveys | 1 | 2011 | 494 | 0.080 |
Why?
| | Young Adult | 7 | 2021 | 12426 | 0.080 |
Why?
| | Orthotic Devices | 1 | 2008 | 23 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 596 | 0.070 |
Why?
| | Elasticity | 1 | 2009 | 196 | 0.070 |
Why?
| | Asthma | 1 | 2021 | 2230 | 0.070 |
Why?
| | Splenorenal Shunt, Surgical | 1 | 2007 | 3 | 0.070 |
Why?
| | Insurance, Health | 2 | 2022 | 267 | 0.070 |
Why?
| | Gait Disorders, Neurologic | 1 | 2008 | 44 | 0.070 |
Why?
| | Vitamin D | 1 | 2011 | 384 | 0.070 |
Why?
| | Brachial Artery | 1 | 2009 | 192 | 0.070 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 280 | 0.070 |
Why?
| | Mycoses | 1 | 2008 | 71 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1266 | 0.070 |
Why?
| | Esophageal and Gastric Varices | 1 | 2007 | 37 | 0.070 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2007 | 41 | 0.070 |
Why?
| | Hip Joint | 1 | 2008 | 158 | 0.070 |
Why?
| | Diabetic Angiopathies | 1 | 2009 | 261 | 0.070 |
Why?
| | Veterans | 1 | 2018 | 1398 | 0.070 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2007 | 121 | 0.070 |
Why?
| | Medical Staff | 1 | 2006 | 16 | 0.070 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 1098 | 0.060 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2006 | 42 | 0.060 |
Why?
| | Staff Development | 1 | 2006 | 57 | 0.060 |
Why?
| | Diskectomy | 1 | 2005 | 21 | 0.060 |
Why?
| | Adolescent | 9 | 2021 | 20393 | 0.060 |
Why?
| | Cross-Sectional Studies | 4 | 2024 | 5066 | 0.060 |
Why?
| | Heart Failure | 4 | 2016 | 2150 | 0.060 |
Why?
| | Splanchnic Circulation | 1 | 2005 | 10 | 0.060 |
Why?
| | Survival Analysis | 4 | 2010 | 1274 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2006 | 78 | 0.060 |
Why?
| | Mesenteric Artery, Superior | 1 | 2005 | 15 | 0.060 |
Why?
| | Prospective Studies | 5 | 2022 | 7133 | 0.060 |
Why?
| | Complementary Therapies | 1 | 2006 | 87 | 0.060 |
Why?
| | Intervertebral Disc | 1 | 2005 | 39 | 0.060 |
Why?
| | Intervertebral Disc Displacement | 1 | 2005 | 39 | 0.060 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 122 | 0.060 |
Why?
| | Health Status | 2 | 2021 | 755 | 0.060 |
Why?
| | Proctocolectomy, Restorative | 1 | 2005 | 19 | 0.060 |
Why?
| | Ileostomy | 1 | 2005 | 20 | 0.060 |
Why?
| | Astrocytoma | 1 | 2006 | 122 | 0.060 |
Why?
| | Poisson Distribution | 1 | 2005 | 73 | 0.060 |
Why?
| | Hyperthermia, Induced | 1 | 2005 | 109 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2011 | 1269 | 0.060 |
Why?
| | Anterior Cruciate Ligament | 1 | 2005 | 80 | 0.060 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2005 | 117 | 0.060 |
Why?
| | Seroepidemiologic Studies | 1 | 2024 | 156 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2017 | 1279 | 0.050 |
Why?
| | Low Back Pain | 1 | 2005 | 105 | 0.050 |
Why?
| | Cardiology | 1 | 2006 | 261 | 0.050 |
Why?
| | Models, Biological | 1 | 2010 | 1722 | 0.050 |
Why?
| | Analysis of Variance | 2 | 2020 | 1288 | 0.050 |
Why?
| | Lung | 1 | 2016 | 3930 | 0.050 |
Why?
| | Waist Circumference | 2 | 2014 | 138 | 0.050 |
Why?
| | Multiple Sclerosis | 1 | 2008 | 436 | 0.050 |
Why?
| | Breast Diseases | 1 | 2002 | 22 | 0.050 |
Why?
| | Nipples | 1 | 2002 | 8 | 0.050 |
Why?
| | Urinalysis | 1 | 2023 | 75 | 0.050 |
Why?
| | Ambulatory Care Facilities | 2 | 2017 | 228 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1894 | 0.050 |
Why?
| | Pneumonia | 1 | 2008 | 616 | 0.050 |
Why?
| | Catheter Ablation | 1 | 2005 | 335 | 0.050 |
Why?
| | Laboratories | 1 | 2023 | 110 | 0.050 |
Why?
| | Relative Value Scales | 1 | 2021 | 5 | 0.050 |
Why?
| | Microscopy | 1 | 2023 | 141 | 0.050 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 2 | 2015 | 198 | 0.050 |
Why?
| | Contraceptive Agents | 1 | 2022 | 65 | 0.050 |
Why?
| | Work-Life Balance | 1 | 2021 | 19 | 0.040 |
Why?
| | ROC Curve | 3 | 2008 | 503 | 0.040 |
Why?
| | Diabetes Mellitus | 3 | 2016 | 1001 | 0.040 |
Why?
| | Ultrasonography, Doppler | 2 | 2015 | 118 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 147 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3381 | 0.040 |
Why?
| | Biomarkers | 3 | 2020 | 3973 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2022 | 219 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2012 | 1952 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1214 | 0.040 |
Why?
| | United States Public Health Service | 1 | 2019 | 9 | 0.040 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 485 | 0.040 |
Why?
| | Clinical Clerkship | 1 | 2021 | 95 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2006 | 1356 | 0.040 |
Why?
| | Health Services Needs and Demand | 2 | 2015 | 264 | 0.040 |
Why?
| | Postoperative Complications | 3 | 2006 | 2483 | 0.040 |
Why?
| | Sulfonylurea Compounds | 2 | 2010 | 46 | 0.040 |
Why?
| | Mentors | 1 | 2021 | 178 | 0.040 |
Why?
| | Injections, Intra-Arterial | 1 | 2018 | 25 | 0.040 |
Why?
| | Adiposity | 2 | 2014 | 504 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2018 | 201 | 0.040 |
Why?
| | Linear Models | 1 | 2020 | 819 | 0.040 |
Why?
| | Child | 6 | 2021 | 20883 | 0.040 |
Why?
| | Brain Neoplasms | 1 | 2006 | 1171 | 0.030 |
Why?
| | Acute Disease | 2 | 2010 | 980 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2018 | 306 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 148 | 0.030 |
Why?
| | Child, Preschool | 3 | 2021 | 10517 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 629 | 0.030 |
Why?
| | beta 2-Microglobulin | 1 | 2015 | 49 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 348 | 0.030 |
Why?
| | Protective Factors | 1 | 2016 | 91 | 0.030 |
Why?
| | Cystatin C | 1 | 2015 | 65 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 642 | 0.030 |
Why?
| | Survivors | 2 | 2009 | 464 | 0.030 |
Why?
| | Prevalence | 2 | 2013 | 2564 | 0.030 |
Why?
| | Smoking | 2 | 2016 | 1501 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1838 | 0.030 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 89 | 0.030 |
Why?
| | Potassium | 1 | 2015 | 143 | 0.030 |
Why?
| | Lumbosacral Region | 1 | 2015 | 56 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 248 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 298 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2006 | 422 | 0.030 |
Why?
| | Equipment Failure | 1 | 2015 | 107 | 0.030 |
Why?
| | Blood Glucose | 2 | 2015 | 2097 | 0.030 |
Why?
| | Leptin | 1 | 2015 | 219 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 356 | 0.030 |
Why?
| | Personnel Selection | 1 | 2015 | 72 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2014 | 57 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 586 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 635 | 0.030 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2014 | 66 | 0.030 |
Why?
| | Phosphorus | 1 | 2014 | 93 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1213 | 0.030 |
Why?
| | Adiponectin | 1 | 2015 | 235 | 0.030 |
Why?
| | Hypogonadism | 1 | 2014 | 84 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2015 | 273 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2015 | 306 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2014 | 117 | 0.030 |
Why?
| | Glucose Metabolism Disorders | 1 | 2013 | 11 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2015 | 401 | 0.030 |
Why?
| | Life Style | 1 | 2015 | 460 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 5406 | 0.030 |
Why?
| | Hyperparathyroidism | 1 | 2012 | 11 | 0.030 |
Why?
| | Hypoalbuminemia | 1 | 2012 | 30 | 0.020 |
Why?
| | Anthropometry | 1 | 2012 | 204 | 0.020 |
Why?
| | Hemoglobins | 1 | 2014 | 339 | 0.020 |
Why?
| | Body Composition | 1 | 2015 | 649 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 1092 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2013 | 177 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2070 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 1902 | 0.020 |
Why?
| | Glipizide | 1 | 2010 | 6 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2002 | 2142 | 0.020 |
Why?
| | Length of Stay | 2 | 2006 | 1127 | 0.020 |
Why?
| | Glyburide | 1 | 2010 | 35 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 993 | 0.020 |
Why?
| | Heart-Lung Transplantation | 1 | 2009 | 10 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 625 | 0.020 |
Why?
| | Educational Status | 1 | 2011 | 470 | 0.020 |
Why?
| | Seasons | 1 | 2011 | 502 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2535 | 0.020 |
Why?
| | Europe | 1 | 2009 | 364 | 0.020 |
Why?
| | North America | 1 | 2009 | 291 | 0.020 |
Why?
| | Thiazolidinediones | 1 | 2009 | 137 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 263 | 0.020 |
Why?
| | Calcium | 1 | 2014 | 1213 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2008 | 152 | 0.020 |
Why?
| | Tacrolimus | 1 | 2009 | 193 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 559 | 0.020 |
Why?
| | Quality-Adjusted Life Years | 1 | 2007 | 106 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 793 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2009 | 224 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2717 | 0.020 |
Why?
| | Dialysis | 1 | 2006 | 18 | 0.020 |
Why?
| | Primary Health Care | 1 | 2017 | 1680 | 0.020 |
Why?
| | Salvage Therapy | 1 | 2007 | 134 | 0.020 |
Why?
| | Negativism | 1 | 2006 | 4 | 0.020 |
Why?
| | Equipment Design | 1 | 2008 | 514 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2007 | 218 | 0.020 |
Why?
| | Religion and Psychology | 1 | 2006 | 27 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2006 | 34 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 366 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2006 | 90 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2004 | 0.020 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 102 | 0.020 |
Why?
| | Morbidity | 1 | 2006 | 302 | 0.020 |
Why?
| | Gait | 1 | 2008 | 280 | 0.020 |
Why?
| | Muscle Strength | 1 | 2008 | 303 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2005 | 36 | 0.010 |
Why?
| | Activities of Daily Living | 1 | 2008 | 384 | 0.010 |
Why?
| | Metformin | 1 | 2009 | 315 | 0.010 |
Why?
| | Surgical Stapling | 1 | 2005 | 14 | 0.010 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 569 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2006 | 202 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2005 | 149 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2009 | 853 | 0.010 |
Why?
| | Suture Techniques | 1 | 2005 | 118 | 0.010 |
Why?
| | Patient Satisfaction | 1 | 2008 | 634 | 0.010 |
Why?
| | Histological Techniques | 1 | 2004 | 40 | 0.010 |
Why?
| | Teaching | 1 | 2006 | 214 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2006 | 940 | 0.010 |
Why?
| | Quality of Life | 1 | 2015 | 2704 | 0.010 |
Why?
| | Perioperative Care | 1 | 2005 | 152 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2010 | 894 | 0.010 |
Why?
| | Neoplasms | 1 | 2018 | 2470 | 0.010 |
Why?
| | Viremia | 1 | 2004 | 131 | 0.010 |
Why?
| | Pain Measurement | 1 | 2005 | 506 | 0.010 |
Why?
| | Papilloma | 1 | 2002 | 48 | 0.010 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2005 | 226 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 448 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2006 | 850 | 0.010 |
Why?
| | Hyperplasia | 1 | 2002 | 171 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2006 | 718 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2004 | 644 | 0.010 |
Why?
| | Pilot Projects | 1 | 2006 | 1587 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1698 | 0.010 |
Why?
| | Pneumonia, Viral | 1 | 2004 | 341 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2006 | 1022 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 6402 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2006 | 2708 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4083 | 0.010 |
Why?
| | Infant | 1 | 2010 | 9024 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2005 | 5762 | 0.010 |
Why?
| | Brain | 1 | 2006 | 2679 | 0.010 |
Why?
|
|
Arrigain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|